Journal of Surgery Concepts & Practice >
Past, present and prospect of retroperitoneal tumor surgery
CHEN Jun, LUO Chenghua . Past, present and prospect of retroperitoneal tumor surgery[J]. Journal of Surgery Concepts & Practice, 2022 , 27(06) : 490 -494 . DOI: 10.16139/j.1007-9610.2022.06.02
| [1] | DeSantis CE, Kramer JL, Jemal A. The burden of rare cancers in the United States[J]. CA Cancer J Clin, 2017, 67(4):261-272. |
| [2] | Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy[J]. Cancer, 2006, 106(7):1610-1616. |
| [3] | Matsuda T, Won YJ, Chun-Ju Chiang R, et al. Rare cancers are not rare in Asia as well: the rare cancer burden in East Asia[J]. Cancer Epidemiol, 2020, 67:101702. |
| [4] | 中华医学会肿瘤学分会, 中华医学会杂志社, 中国医师协会肛肠医师分会腹膜后疾病专业委员会, 等. 中国腹膜后肿瘤诊治专家共识(2019版)[J]. 中华肿瘤杂志, 2019, 41(10):728-733. |
| [5] | Donnelly BA. Primary retroperitoneal tumors; a report of 95 cases and a review of the literature[J]. Surg Gynecol Obstet, 1946, 83(6):705-717. |
| [6] | HJ W. Primary retroperitoneal sarcoma[J]. Am J Med Sci, 1903, 126:269-276. |
| [7] | Judd ES. Retroperitoneal tumors[J]. S Clin North Am, 1933,823. |
| [8] | Haas R, Stelmes JJ, Zaffaroni F, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: results from the EORTC 62092-22092 STRASS trial[J]. Cancer, 2022, 128(14):2796-2805. |
| [9] | Pack GT, Tabah EJ. Primary retroperitoneal tumors: a study of 120 cases[J]. Int Abstr Surg, 1954, 99(4):313-341. |
| [10] | Cody HS 3rd, Turnbull AD, Fortner JG, et al. The continuing challenge of retroperitoneal sarcomas[J]. Cancer, 1981, 47(9):2147-2152. |
| [11] | Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma[J]. Ann Surg, 1991, 214(1):2-10. |
| [12] | 孟承伟, 胡永昌. 原发性腹膜后肿瘤:64例分析[J]. 中华外科杂志, 1960, 8(6)547-550. |
| [13] | 陈凛, 李荣, 石怀银, 等. 原发性腹膜后肿瘤600例临床研究[J]. 中国肿瘤, 2003, 12(10):611-613. |
| [14] | Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients[J]. J Clin Oncol, 2009, 27(1):24-30. |
| [15] | Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control[J]. J Clin Oncol, 2009, 27(1):31-37. |
| [16] | Callegaro D, Miceli R, Brunelli C, et al. Long-term morbidity after multivisceral resection for retroperitoneal sarcoma[J]. Br J Surg, 2015, 102(9):1079-1087. |
| [17] | Gronchi A, Miceli R, Colombo C, et al. Frontline exten-ded surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas[J]. Ann Oncol, 2012, 23(4):1067-1073. |
| [18] | MacNeill AJ, Gronchi A, Miceli R, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the Transatlantic RPS Wor-king Group[J]. Ann Surg, 2018, 267(5):959-964. |
| [19] | Casali PG, Abecassis N, Aro HT, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2018, 29(Suppl 4):iv268-iv269. |
| [20] | Istl AC, Gronchi A. Neoadjuvant therapy for primary resectable retroperitoneal sarcomas-looking forward[J]. Cancers(Basel), 2022, 14(7):1831. |
| [21] | Dickson MA, Tap WD, Keohan ML, et al. Phase Ⅱ trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma[J]. J Clin Oncol, 2013, 31(16):2024-2028. |
| [22] | Mahmood ST, Agresta S, Vigil CE, et al. Phase Ⅱ study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous his-tiocytoma[J]. Int J Cancer, 2011, 129(8):1963-1969. |
/
| 〈 |
|
〉 |
